Abstract. This 
The role of prolactin in the development of breast disease is far from clear. The hormone depen¬ dence of rodent mammary tumours to prolactin has been demonstrated in vitro and in vivo (Smithline et al. 1975 ; Welsch & Nagasawa 1977) . In humans, however, it is controversial whether pro¬ lactin levels differ in normal women and in women with breast cancer (Nagasawa 1979) . The treat¬ ment of this disease with inhibitors of prolactin secretion is not followed by remission Engelsman et al. 1975) . In mammary dysplasia the serum prolactin concentrations are usually normal (Franks et al. 1974; Boyns et al. 1973 ; Gorins & Netter 1974) although moderately elevated values (< 50 ng/ml) have been found in some series (Franks et al. 1974) . When average nycthemeral prolactin concentrations are estimated in patients with cystic dysplasia it is found that the values, although within the normal range, are significantly higher than those observed in control populations (Cole et al. 1977 
Results
The results are summarized in Table 1 and Fig. 1 .
From the data in Table 1 (Wolfe 1976b) 
